NCT07169136View on ClinicalTrials.gov

Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 11, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Polycystic Ovarian Syndrome in Adolescent FemalesObesity (Disorder)

Interventions

DRUG

GLP-1 Receptor Agonists

Weekly subcutaneous Semaglutide.

Trial Locations (1)

32207

RECRUITING

Nemours Children's Clinic, Jacksonville

All Listed Sponsors

lead

Nemours Children's Clinic

OTHER

NCT07169136 - Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS) | Biotech Hunter | Biotech Hunter